Vimarsana
Biggest News Aggregation in the World

Page 5 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting - Vimarsana News

HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting

HOOKIPA to present an oral abstract at the American Society for Clinical Oncology 2024 Annual Meeting on June 4Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile and...

Hookipa Pharma's (HOOK) "Outperform" Rating Reaffirmed at Royal Bank of Canada - Vimarsana News

Hookipa Pharma's (HOOK) "Outperform" Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $5.00 price target on the stock. Separately, HC Wainwright reduced their price target on shares of Hookipa Pharma from […]

North American Morning Briefing : Caution Dominates Ahead of Nvidia, FOMC Minutes - Vimarsana News

North American Morning Briefing : Caution Dominates Ahead of Nvidia, FOMC Minutes

OPENING CALL Stock futures drifted lower and bond yields rose on Wednesday as investors eyed minutes from the Federal Reserve's May meeting and higher-than-expected U.K. inflation reminded the...

IGC Pharma to Attend BIO International Convention 2024 - Vimarsana News

IGC Pharma to Attend BIO International Convention 2024

IGC Pharma, Inc , today announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6, 2024. During the...

Analyzing DocuSign (NASDAQ:DOCU) & Oncology Pharma (OTCMKTS:ONPH) - Vimarsana News

Analyzing DocuSign (NASDAQ:DOCU) & Oncology Pharma (OTCMKTS:ONPH)

DocuSign (NASDAQ:DOCU – Get Free Report) and Oncology Pharma (OTCMKTS:ONPH – Get Free Report) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Volatility and Risk DocuSign has a beta of […]

Source: wkrb13.com